DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Epicatechin is an investigational drug.
There have been 13 clinical trials for Epicatechin. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2016.
The most common disease conditions in clinical trials are Muscular Dystrophies, Muscular Dystrophy, Duchenne, and Glucose Intolerance. The leading clinical trial sponsors are Cardero Therapeutics, Inc., National Center for Complementary and Integrative Health (NCCIH), and Craig McDonald, MD.
Recent Clinical Trials for Epicatechin
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Cardero Therapeutics, Inc.||Phase 1/Phase 2|
|Plus Epicatechin Duchenne Muscular Dystrophy in Non-ambulatory Adolescents||Craig McDonald, MD||Phase 1/Phase 2|
|(-)- Epicatechin Becker Muscular Dystrophy||Cardero Therapeutics, Inc.||Phase 2|